Tirzepatide 30mg
For laboratory research use only. Not for human or veterinary use, and not for diagnostic procedures. Not a drug, food, cosmetic or natural health product, and not authorized by Health Canada. Identity and purity figures are those on the lot's Certificate of Analysis, not a sitewide guarantee. Buyers are responsible for complying with applicable laws.
Specifications
- form
- Lyophilized powder
- use
- Research use only
- documentation
- See lot COAPurity: see published lot COA
Identity and purity numbers are the figures on the lot file, not a sitewide guarantee.
Documentation (HPLC / UPLC, MS, COA)
Published lots for this SKU are listed at the exact certificate section. Identity is typically confirmed by mass spectrometry; purity by HPLC / UPLC. A report for another peptide or fill size does not document this vial.
Research context
Tirzepatide 30 mg is the black-cap research peptide fill. The published mass and endotoxin reports name this 30 mg sample. A 10 mg yellow-cap file does not document this vial. Research use only.
Tirzepatide Peptide (30 mg)
Dual GIP / GLP‑1 Receptor Agonist for Advanced Metabolic Research in Canada
Tirzepatide peptide is a synthetic dual‑agonist research compound studied in laboratory settings for its interaction with GIP (glucose‑dependent insulinotropic polypeptide) and GLP‑1 (glucagon‑like peptide‑1) receptor pathways. Its unique ability to engage two incretin receptor systems simultaneously makes it a valuable tool in advanced metabolic and signalling research.
Supplied by BlueNex Labs, Tirzepatide is provided as a lyophilized research peptide (30 mg) with a published lot file when one exists, optimized for Canadian research laboratories requiring audit‑safe RUO reagents.
Overview of Tirzepatide in Research Settings
Tirzepatide is designed as a synthetic peptide analogue that enables controlled investigation of multi‑receptor incretin signalling in in‑vitro and preclinical research models. By activating both GIPR and GLP‑1R, it supports experimental exploration of how coordinated receptor engagement influences:
- Metabolic signal integration
- Energy‑regulation pathways
- Receptor bias and signalling efficiency
- Peptide structure–function relationships
Because of its dual‑agonist architecture, Tirzepatide is frequently used as a model compound in studies examining multi‑pathway peptide mechanisms and receptor crosstalk.
Research Applications (Non‑Medical)
Tirzepatide is intended strictly for laboratory research use and is commonly applied in:
- Dual‑receptor binding studies
- cAMP & intracellular signalling assays
- Peptide–receptor kinetics research
- Structure–function & stability studies
- Analytical & method development
All applications remain non‑clinical and research‑only.
Molecular & Chemical Characteristics
Type: Synthetic dual‑agonist peptide (GIPR + GLP‑1R)
Form: Lyophilized peptide powder
Size: 30 mg vial
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC
Structural Features
- Sequence‑level substitutions designed to improve enzymatic stability
- Fatty‑acid side chain enabling albumin interaction in vitro
- Demonstrates dual‑receptor engagement with measurable receptor bias
Biochemical Behaviour
- Solubility dependent on pH, buffer system, and ionic strength
- Lipidated peptides may aggregate if improperly prepared
❄️ Storage & Handling Guidelines
- Store lyophilized peptide at −20 °C, protected from light and moisture
- Avoid repeated freeze–thaw cycles; aliquot according to your laboratory SOP
- Use low‑binding laboratory consumables to reduce peptide adsorption
📄 Certificate of Analysis (COA) & Documentation
Each batch of Tirzepatide supplied by BlueNex Labs includes audit‑ready documentation, consisting of:
- MS identity confirmation
- HPLC / UPLC purity results
- Solvent system disclosure
- Lot & batch traceability
🔗 View Certificate of Analysis (COA)
🔗Learn About Our Testing Standards
Learn about documentation standards in the FAQ
Task 233053 is the black-cap 30 mg mass and purity report for sample TR30 (batch not stated): Tirzepatide 32.70 mg, purity 99.806%. The scan is in the Tirzepatide 30 mg certificate section. The endotoxin link on that row is a separate published test. Those files do not document the Tirzepatide 10 mg yellow-cap vial. Tirzepatide lots are research use only. Confirm the vial size on the Certificate of Analysis; a 30 mg report does not document a 10 mg fill.
Compliance Notice
Research use only. Not for human or veterinary use. No medical, cosmetic, or performance claims are made or implied.
Canada fulfilment
- Ships inside Canada only on Canada Post Xpresspost after Interac e-Transfer. $25.00 flat rate; free on product subtotals of $299.00 or more.
- Orders ship within 24 hours of payment confirmation, and your Xpresspost tracking number is emailed when the label is created so you can follow the package with Canada Post.
- A tracking number is emailed when the label is created. A payment confirmation email is sent once the e-Transfer is received. Weekday cutoff: payments received after 12 pm PT on a business day, or on a weekend or statutory holiday, are processed the next business day. Transit is typically 1–3 business days in most urban areas and 3–7 business days for rural and remote areas. Estimates are not guarantees.
- Our desk is at 4309 Canada Way, Burnaby, BC V5G 1J3. Labels use a Port Moody, BC PO Box. Provincial fulfilment FAQ.
Questions about laboratory procurement? Contact BlueNex Labs.
Questions about this listing
How do I match a tirzepatide 30 mg lot to its Certificate of Analysis?
This shop URL is the 30 mg black-cap fill. Open the certificate for this product. Task 233053 is the mass and purity report for sample TR30. Batch not stated on the report. Tirzepatide 32.70 mg, purity 99.806%. The endotoxin link on that row is a separate published test. The 10 mg yellow-cap listing is Tirzepatide 10 mg. A 30 mg file does not document a 10 mg vial.
What does research-use-only mean on the tirzepatide 30 mg listing?
Tirzepatide 30 mg is sold for laboratory work. It is not a medicine, food, cosmetic, or veterinary product. Research-use-only labelling is not a Health Canada authorization. Authorized drugs in Canada carry a Drug Identification Number.
How is tirzepatide 30 mg shipped and paid for in Canada?
Paid orders ship on Canada Post Xpresspost inside Canada after Interac e-Transfer to BlueNexLabs@gmail.com. Put the order number in the Interac message field. $25.00 flat rate; free on product subtotals of $299.00 or more. Our desk is at 4309 Canada Way, Burnaby, BC V5G 1J3. Labels use a Port Moody, BC PO Box. The catalogue does not ship outside Canada.
Where are storage notes for a tirzepatide 30 mg vial?
Tirzepatide 30 mg arrives as a lyophilized research solid. Move the sealed vial into controlled storage the same day. Receiving notes are on the peptide storage and handling guide. That page does not set a solvent volume. Write 30 mg and black cap on the receiving line before you attach a report.
How much is Tirzepatide 30 mg in Canada?
Tirzepatide 30 mg is $90.00 CAD for 30 mg. Payment is Interac e-Transfer. Shipping is Canada Post Xpresspost across Canada: $25.00 flat rate; free on product subtotals of $299.00 or more. Research use only. Not for human or veterinary use.